Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov - Top-Institutions - MDSpire

Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov

  • By

  • Yun Dai

  • Xue-Ting Li

  • Yong-Shen Zheng

  • Jin-Hai Chen

  • Guo-Xing Xu

  • Hai-Xing Wang

  • December 3, 2025

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Surgical Oncology
    • Clinical Research

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Endoscopic Surgery
    • Clinical Trials

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Surgical Oncology
    • Clinical Research

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Endoscopic Surgery
    • Clinical Trials

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Endoscopic Surgery
    • Clinical Research

Original Source(s)

Evaluating Research Inefficiencies in Randomized Clinical Trials for Endoscopic Resection of Gastrointestinal Lesions: A Cross-Sectional Analysis of ClinicalTrials.gov

  • by Yun Dai, Xue-Ting Li, Yong-Shen Zheng, Jin-Hai Chen, Guo-Xing Xu, Hai-Xing Wang

  • December 3, 2025

Related Content

Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models